Skip to content

Behavioral therapy of nonalcoholic fatty liver disease (NAFLD)

Evaluation system of quality of life and new strategy on behavioral therapy of nonalcoholic fatty liver disease (NAFLD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-13003751
Enrollment
Unknown
Registered
2013-10-30
Start date
2013-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

Obervation group:Diet and exercise
control:NA

Sponsors

Tianjin Second People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of non-alcoholic fatty liver disease (NAFLD) according to Guidelines for diagnosis and treatment of nonalcoholic fatty liver disease revised by Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association in 2010; 2. Males or females aged from 18-70 years old; 3. ALT or AST less than80 u/L; 4. Informed consent has been obtained before commencement of the study.

Exclusion criteria

Exclusion criteria: 1. History of Alcohol intake>20g/d; 2. Co-existing of other liver diseases, such as viral, drug-induced, auto-immune hepatitis and so on; 3. Suspicion of liver cirrhosis or liver cancer; 4. Co-existing of other severe systematic disease or infectious disease, such as malignant neoplasm, severe cardiopulmonary disease, neurological disorders, HIV infection and so on; 5. Unable to control diet or to conduct aerobic exercise; 6. Currently pregnant, breastfeeding, pregnancy anticipated during study or planning to be conceive; 7. Co-existing of mental disorders or severe neurosis, or unable to express symptoms subjectively and hindering connection and cooperation with researchers because of dysgnosia or aphasis.

Design outcomes

Primary

MeasureTime frame
Weight;Waist;Liver function;Blood lipid;Blood glucos;

Countries

China

Contacts

Public ContactYuqiang Mi

Tianjin Second People's Hospital

yuqiangmi68@163.com+86 022-27468003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026